| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/03/2012 | CA2375034C Method and device for analysis of biological specimens |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2347025C Zinc finger binding domains for gnn |
| 01/03/2012 | CA2344619C Constructing and screening a dna library of interest in filamentous fungal cells |
| 01/03/2012 | CA2337490C Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 01/03/2012 | CA2309586C Genomics via optical mapping with ordered restriction maps |
| 01/03/2012 | CA2258348C Screening compounds for the ability to alter the production of amyloid-.beta. peptide (x-.gtoreq.41) |
| 01/03/2012 | CA2248893C Graphitic nanotubes in luminescence assays |
| 01/03/2012 | CA2226973C Modulators of the function of fas receptors and other proteins |
| 01/03/2012 | CA2178482C Thrombopoietin |
| 12/29/2011 | WO2011163639A2 Cell aging as a unique biomarker of major depression |
| 12/29/2011 | WO2011163627A2 Organ specific diagnostic panels and methods for identification of organ specific panel proteins |
| 12/29/2011 | WO2011163607A2 Olfactory receptor copy number association with age at onset of alzheimer's disease |
| 12/29/2011 | WO2011163590A1 Compositions and methods for enhancing resistance to northern leaf blight in maize |
| 12/29/2011 | WO2011163554A2 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis |
| 12/29/2011 | WO2011163526A2 Signal activated molecular delivery |
| 12/29/2011 | WO2011163497A2 Method for determining predisposition to esophageal-related disorders |
| 12/29/2011 | WO2011163425A1 Sequence specific real-time monitoring of loop-mediated isothermal amplification (lamp) |
| 12/29/2011 | WO2011163370A2 Analysis of microneutralization assay using curve-fitting constraints |
| 12/29/2011 | WO2011163323A2 Modified carbonic anhydrase enzymes and their use in carbon dioxide sequestration and elimination |
| 12/29/2011 | WO2011163303A2 Sensor systems having multiple probes and electrode arrays |
| 12/29/2011 | WO2011163249A2 Compositions, kits, and methods for synthesis and/or detection of nucleic acids |
| 12/29/2011 | WO2011163214A2 Microrna profiles for evaluating multiple sclerosis |
| 12/29/2011 | WO2011163120A1 Compositions, methods and kits for nucleic acid synthesis and amplification |
| 12/29/2011 | WO2011162894A1 Detection of nucleic acids and proteins |
| 12/29/2011 | WO2011162805A2 Prion inactivation using ozone |
| 12/29/2011 | WO2011162603A1 Method for determining one or more characterizing features of a macromolecule and an apparatus for carrying out said method |
| 12/29/2011 | WO2011162582A2 Dna analysis device using nano pore structure, analysis method and pcr quantitative detecting device |
| 12/29/2011 | WO2011162441A1 Primer pairs for detecting orientia tsutsugamushi and detection method using the same |
| 12/29/2011 | WO2011162326A1 Rna strand storage solution |
| 12/29/2011 | WO2011162317A1 Method for determination or evaluation of substance of interest |
| 12/29/2011 | WO2011162295A1 Detection method for novel ros1 fusion product |
| 12/29/2011 | WO2011162285A1 Composition for preventing evaporation of reaction solution during nucleic acid amplification reaction |
| 12/29/2011 | WO2011162213A1 Method for detecting microorganisms, device for detecting microorganisms and program |
| 12/29/2011 | WO2011162115A1 PHARMACEUTICAL COMPOSITION UTILIZING PANCREATIC β CELL PROLIFERATION FACTOR |
| 12/29/2011 | WO2011161962A1 Method and device for identifying multipotent stem cell colony, and method and device for automatic culturing of multipotent stem cells |
| 12/29/2011 | WO2011161700A1 Genetic markers for risk management of vascular disease |
| 12/29/2011 | WO2011161420A2 Coincidence detection |
| 12/29/2011 | WO2011161413A2 Method and device |
| 12/29/2011 | WO2011161388A1 Device for determining or studying the state of stimulation of the natural defences of plants or portions of plants |
| 12/29/2011 | WO2011161253A1 Editing profiling of pde8a pre -mrna : use as specific biomarker of adars activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects |
| 12/29/2011 | WO2011161239A1 Method of detecting ribonucleic acids |
| 12/29/2011 | WO2011161199A1 Highly sensitive method for detection of a target nucleic acid in a sample |
| 12/29/2011 | WO2011161186A1 Method for in vitro diagnosing sepsis utilizing biomarker composed of more than two different types of endogenous biomolecules |
| 12/29/2011 | WO2011160989A1 Nano-fluidic field effective device to control dna transport through a nano channel comprising a set of electrodes |
| 12/29/2011 | WO2011160887A1 Soluble quencher to reduce background in qpcr assays |
| 12/29/2011 | WO2011160848A1 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| 12/29/2011 | WO2011160767A1 Gene expression analyses for characterizing and identifying genotoxic compounds |
| 12/29/2011 | WO2011160599A1 Method and composition for targeting vicious cycles of stresses and inflammatory responses |
| 12/29/2011 | WO2011160585A1 Micro-rna markers for colorectal cancer |
| 12/29/2011 | WO2011160573A1 Method for producing rifamycin sv with high activity and high purity |
| 12/29/2011 | WO2011160237A1 Genetic markers associated with intellectual disability |
| 12/29/2011 | WO2011160206A1 Biomarkers for non-hodgkin lymphomas and uses thereof |
| 12/29/2011 | WO2011139955A3 Multi-targeted priming for genome-wide gene expression assays |
| 12/29/2011 | WO2011138676A3 Integrated microfluidic sensor system with magnetostrictive resonators |
| 12/29/2011 | WO2011135194A3 Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes |
| 12/29/2011 | WO2011130635A3 Primers, probes, methods and kits for the detection of eml4-alk variants |
| 12/29/2011 | WO2011130119A8 Methods of producing high titer, high purity virus stocks and methods of use thereof |
| 12/29/2011 | WO2011123166A3 Methods and systems for reducing dna fragmentation in a processed sperm sample |
| 12/29/2011 | WO2011116244A3 Methods of diagnosing and treating conditions associated with metabolic clearance rate of insulin |
| 12/29/2011 | WO2011100374A3 Mediator and cohesin connect gene expression and chromatin architecture |
| 12/29/2011 | WO2011094572A3 Hanging drop devices, systems and/or methods |
| 12/29/2011 | WO2011090351A3 Diagnostic method and diagnosing kit for prostatitis |
| 12/29/2011 | WO2011085163A3 Protein markers for lung cancer detection and methods of using thereof |
| 12/29/2011 | WO2011056975A4 Genetically encoded calcium indicators and methods of use |
| 12/29/2011 | WO2011039757A3 Compositions and methods for prognosis of renal cancer |
| 12/29/2011 | WO2009143590A8 Insertion sequence detection protocol |
| 12/29/2011 | WO2009024834A3 Nucleic acids involved in viral infection |
| 12/29/2011 | WO2008019351A8 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| 12/29/2011 | WO2006086284A9 Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby |
| 12/29/2011 | US20110321197 Plants with Increased Yield (NUE) |
| 12/29/2011 | US20110321192 Tomato plants having higher levels of resistance to botrytis |
| 12/29/2011 | US20110321189 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 12/29/2011 | US20110321186 Modulation of plant cell wall deposition via hdzipi |
| 12/29/2011 | US20110321182 Selection of animals for desired milk and/or tissue profile |
| 12/29/2011 | US20110319605 Purification of a triple helix formation with an immobilized oligonucleotide |
| 12/29/2011 | US20110319602 T2r taste receptors and genes encoding same |
| 12/29/2011 | US20110319477 Mutations of the pik3ca gene in human cancers |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 12/29/2011 | US20110319474 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
| 12/29/2011 | US20110319472 Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms |
| 12/29/2011 | US20110319470 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 12/29/2011 | US20110319469 SNPs of Apolipoprotein B and Modulation of Their Expression |
| 12/29/2011 | US20110319451 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders |
| 12/29/2011 | US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity |
| 12/29/2011 | US20110319415 Susceptibility to HSP90-Inhibitors |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110319337 Dominant Negative WNT2 Compositions and Methods of Use |
| 12/29/2011 | US20110319336 Selective anticancer chimeric peptide |
| 12/29/2011 | US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases |
| 12/29/2011 | US20110319327 Polypeptides Homologous to VEGF and BMP1 |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110319295 MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY |
| 12/29/2011 | US20110319293 Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay |
| 12/29/2011 | US20110319289 Molecular-based method of cancer diagnosis and prognosis |
| 12/29/2011 | US20110319288 Bank1 related snps and sle and/or ms susceptibility |
| 12/29/2011 | US20110319286 System for screening agonists/antagonists of cellular signaling pathways |
| 12/29/2011 | US20110319284 Method for determining the predisposition for crohn's disease |
| 12/29/2011 | US20110319283 Oligonucleotides capable of discriminating between nucleic acid sequences that comprise a conserved sequence |